Editorial: risk of loss of response to anti TNFα in patients with inflammatory bowel diseases – the longer the less? Authors' reply

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

Original language	English
Pages (from-to)	246-246
Number of pages	1
Journal	Alimentary Pharmacology & Therapeutics
Volume	55
Issue number	2
DOIs	https://doi.org/10.1111/apt.16722
Publication status	Published - Jan 2022

Access to Document

@article{945a2422f5484fd1b719ff97fdb46b26,

title = "Editorial: risk of loss of response to anti TNFα in patients with inflammatory bowel diseases – the longer the less? Authors' reply",

author = "Schultheiss, \{Johannes P D\} and Remi Mahmoud and Fidder, \{Herma H\} and Bas Oldenburg",

year = "2022",

month = jan,

doi = "10.1111/apt.16722",

language = "English",

volume = "55",

pages = "246--246",

journal = "Alimentary Pharmacology \& Therapeutics",

issn = "0269-2813",

publisher = "John Wiley \& Sons Inc.",

number = "2",

}

TY - JOUR

T1 - Editorial: risk of loss of response to anti TNFα in patients with inflammatory bowel diseases – the longer the less? Authors' reply

AU - Schultheiss, Johannes P D

AU - Mahmoud, Remi

AU - Fidder, Herma H

AU - Oldenburg, Bas

PY - 2022/1

Y1 - 2022/1

UR - https://www.scopus.com/pages/publications/85122155704

U2 - 10.1111/apt.16722

DO - 10.1111/apt.16722

M3 - Editorial

C2 - 34970765

SN - 0269-2813

VL - 55

SP - 246

EP - 246

JO - Alimentary Pharmacology & Therapeutics

JF - Alimentary Pharmacology & Therapeutics

IS - 2

ER -